Stock Market Live July 2, 2026: S&P 500 (SPY) Flat with New Jobs Data

Investing

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1240 Articles

Lee Jackson | Sep 2, 2022 at 7:23 AM EDT

Why 7 Analyst Favorite Dividend Kings Could Be Huge Bear Market Winners

With interest rates rising and inflation stripping bond yields to zilch, these seven Dividend King stocks offer outstanding safety and…

Lee Jackson | Aug 15, 2022 at 7:10 AM EDT

Warren Buffett Owns These 3 Very Safe ‘Strong Buy’ Dividend Kings in Berkshire Hathaway

Often when total return investors look for companies paying big dividends, they are drawn to the Dividend Kings, which have…

Lee Jackson | Jul 22, 2022 at 6:52 AM EDT

Warren Buffett’s Berkshire Hathaway Loves These 4 High-Quality Dividend Aristocrat Stocks

In a market that is very volatile and could be headed much lower if we are actually in a recession,…

Paul Ausick | Jul 15, 2022 at 9:54 AM EDT

Earnings Previews: Halliburton, IBM, Johnson & Johnson, Lockheed Martin, Truist

Here are previews of five companies set to report quarterly results late Monday or early Tuesday, including IBM and Johnson…

Lee Jackson | May 26, 2022 at 7:35 AM EDT

Legendary Wall Street Strategist Says Buy Defensive Value Now: 9 Dividend Stocks Fit the Bill

Given the market's nervousness, Stifel's strategy now is to go with defensive value stocks and selected growth stocks. These nine…

Lee Jackson | May 2, 2022 at 9:52 AM EDT

8 Dividend Aristocrat Leaders to Buy Now With the Stock Market Ready to Blow Up

With the potential for a sizable correction looming, 24/7 Wall St. thought it would be a good idea to look…

Lee Jackson | Apr 18, 2022 at 9:33 AM EDT

5 Analyst Favorite Blue Chip Stocks Are Expected to Have Dividend Hikes This Week

These five top companies are expected to lift the dividends they pay to shareholders this week, making their stocks good…

Paul Ausick | Apr 15, 2022 at 6:37 AM EDT

Earnings Previews: Halliburton, Johnson & Johnson, Lockheed Martin, Truist

Markets are closed Friday, so this earnings preview looks ahead to four companies reporting results before markets open on Tuesday.

Lee Jackson | Apr 13, 2022 at 7:16 AM EDT

5 Elite and Very Safe Dividend Kings Are Also Wall Street Favorites

With even moderate appreciation in these five safe Dividend King stocks, growth and income investors should be looking at double-digit…

Lee Jackson | Apr 4, 2022 at 7:18 AM EDT

5 Very Safe Dividend Aristocrats to Buy Now for What Could Be a Very Rocky Q2

With the potential for a sizable correction looming, here are five Dividend Aristocrats that are in sectors that are defensive…

Lee Jackson | Mar 22, 2022 at 7:18 AM EDT

8 Top Analyst ‘Rock Solid’ Dividend Stocks to Buy Now for Growth, Dependable Income and Safety

Analysts at Jefferies have a dividend playbook for the rest of 2022. They consider these eight blue-chip stock picks in…

Chris Lange | Mar 16, 2022 at 10:40 AM EDT

More Wednesday Analyst Upgrades and Downgrades: Biopharma Stocks Beware — Johnson & Johnson, Edwards Life Sciences and More

Wednesday afternoon's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Constellation Energy, Edwards Lifesciences, Host Hotels & Resorts, Johnson &…

Lee Jackson | Mar 11, 2022 at 7:14 AM EST

The Bear Market Is Growling: 5 Dividend Aristocrats to Buy Now for Safety and Income

With the interest rates about to begin increasing, the Nasdaq close to bear market territory and the market starting to…

Lee Jackson | Mar 3, 2022 at 8:52 AM EST

Thursday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Hewlett Packard Enterprise, Johnson & Johnson, Rivian, Salesforce, SoFi, Target, Zoom Video and More

Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Antero Midstream, C3.ai, Equitrans Midstream, Hewlett Packard Enterprise, iQIYI, Johnson &…

Lee Jackson | Feb 17, 2022 at 7:17 AM EST

5 Very Safe Dividend Aristocrats to Buy Now: Massive Sell-Off Could Be Coming Soon

With the potential for a sizable correction looming and interest rates soon headed higher, it might be a good idea…

1 … 24 25 26 27 28 … 83

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Why 7 Analyst Favorite Dividend Kings Could Be Huge Bear Market Winners

Warren Buffett Owns These 3 Very Safe ‘Strong Buy’ Dividend Kings in Berkshire Hathaway

Warren Buffett’s Berkshire Hathaway Loves These 4 High-Quality Dividend Aristocrat Stocks

Earnings Previews: Halliburton, IBM, Johnson & Johnson, Lockheed Martin, Truist

Legendary Wall Street Strategist Says Buy Defensive Value Now: 9 Dividend Stocks Fit the Bill

8 Dividend Aristocrat Leaders to Buy Now With the Stock Market Ready to Blow Up

5 Analyst Favorite Blue Chip Stocks Are Expected to Have Dividend Hikes This Week

Earnings Previews: Halliburton, Johnson & Johnson, Lockheed Martin, Truist

5 Elite and Very Safe Dividend Kings Are Also Wall Street Favorites

5 Very Safe Dividend Aristocrats to Buy Now for What Could Be a Very Rocky Q2

8 Top Analyst ‘Rock Solid’ Dividend Stocks to Buy Now for Growth, Dependable Income and Safety

More Wednesday Analyst Upgrades and Downgrades: Biopharma Stocks Beware — Johnson & Johnson, Edwards Life Sciences and More

The Bear Market Is Growling: 5 Dividend Aristocrats to Buy Now for Safety and Income

Thursday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Hewlett Packard Enterprise, Johnson & Johnson, Rivian, Salesforce, SoFi, Target, Zoom Video and More

5 Very Safe Dividend Aristocrats to Buy Now: Massive Sell-Off Could Be Coming Soon

Stock Market Live July 2, 2026: S&P 500 (SPY) Flat with New Jobs Data

Cramer to a 23-Year-Old: Buy It, but It Might Take a ‘Lifetime’ to Make Money

Job Openings Rise Again. Is AI Creating Jobs, Not Destroying Them?

Rallying Near Highs: Is TSM a Buy, Sell, or Hold?

A $1.5 Million 401(k) at 73 Can Defer $200,000 in RMDs Past Age 85. Here's How.

Medicare Advantage Looks Cheaper Until You Can't Switch Back: The $1,736 Hospital Deductible Problem

Here’s How Trump Made Over $1.4 Billion On Crypto Last Year, While Bitcoin Went Nowhere

Gold Is Soaring. So Why Has Barrick Fallen Since Its Rebrand?

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Why 7 Analyst Favorite Dividend Kings Could Be Huge Bear Market Winners

Warren Buffett Owns These 3 Very Safe ‘Strong Buy’ Dividend Kings in Berkshire Hathaway

Warren Buffett’s Berkshire Hathaway Loves These 4 High-Quality Dividend Aristocrat Stocks

Earnings Previews: Halliburton, IBM, Johnson & Johnson, Lockheed Martin, Truist

Legendary Wall Street Strategist Says Buy Defensive Value Now: 9 Dividend Stocks Fit the Bill

8 Dividend Aristocrat Leaders to Buy Now With the Stock Market Ready to Blow Up

5 Analyst Favorite Blue Chip Stocks Are Expected to Have Dividend Hikes This Week

Earnings Previews: Halliburton, Johnson & Johnson, Lockheed Martin, Truist

5 Elite and Very Safe Dividend Kings Are Also Wall Street Favorites

5 Very Safe Dividend Aristocrats to Buy Now for What Could Be a Very Rocky Q2

8 Top Analyst ‘Rock Solid’ Dividend Stocks to Buy Now for Growth, Dependable Income and Safety

More Wednesday Analyst Upgrades and Downgrades: Biopharma Stocks Beware — Johnson & Johnson, Edwards Life Sciences and More

The Bear Market Is Growling: 5 Dividend Aristocrats to Buy Now for Safety and Income

Thursday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Hewlett Packard Enterprise, Johnson & Johnson, Rivian, Salesforce, SoFi, Target, Zoom Video and More

5 Very Safe Dividend Aristocrats to Buy Now: Massive Sell-Off Could Be Coming Soon

Stock Market Live July 2, 2026: S&P 500 (SPY) Flat with New Jobs Data

Cramer to a 23-Year-Old: Buy It, but It Might Take a ‘Lifetime’ to Make Money

Job Openings Rise Again. Is AI Creating Jobs, Not Destroying Them?

Rallying Near Highs: Is TSM a Buy, Sell, or Hold?

Featured Reads

A $1.5 Million 401(k) at 73 Can Defer $200,000 in RMDs Past Age 85. Here's How.

Medicare Advantage Looks Cheaper Until You Can't Switch Back: The $1,736 Hospital Deductible Problem